Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
MC Bragazzi, R Venere, E Ribichini, F Covotta… - Digestive and Liver …, 2024 - Elsevier
Intrahepatic cholangiocarcinoma is the second most frequent primary liver cancer after
hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …
hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …
[HTML][HTML] Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
S Lugari, E Baldelli, A Lonardo - Metabolism and Target Organ …, 2023 - oaepublish.com
Primary liver cancer (PLC) is a heterogeneous group of disorders arising with the
background of chronic liver disease (CLD) owing to varying etiologies. PLC carries a high …
background of chronic liver disease (CLD) owing to varying etiologies. PLC carries a high …
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules
and the second-order bile ducts. It is the second most frequent primary liver cancer after …
and the second-order bile ducts. It is the second most frequent primary liver cancer after …
[HTML][HTML] YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to …
C Guan, L Liu, Y Zhao, X Zhang, G Liu, H Wang… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Cholangiocarcinoma is a highly aggressive malignant tumor, and its incidence is increasing
all over the world. More and more evidences show that the aberrant expression of circular …
all over the world. More and more evidences show that the aberrant expression of circular …
[PDF][PDF] 欧洲肝脏研究协会及国际肝癌协会2023 版《 肝内胆管癌治疗临床实践指南》 更新解读
覃德龙， 陈家璐， 唐玥， 汤朝晖， 全志伟 - 中国普通外科杂志, 2023 - zpwz.net
摘要欧洲肝脏研究协会(EASL) 及国际肝癌协会(ILCA) 于2023 年发布最新的《
肝内胆管癌治疗临床实践指南》(简称新版指南). 相较于EASL-ILCA 在2014 …
肝内胆管癌治疗临床实践指南》(简称新版指南). 相较于EASL-ILCA 在2014 …
Survival benefit relative to treatment modalities among patients with very early intrahepatic cholangiocarcinoma: an analysis of the national cancer database
Background Liver transplantation (LT) has been considered a potential curative treatment for
patients with very early intrahepatic cholangiocarcinoma (ICC) and cirrhosis, yet the survival …
patients with very early intrahepatic cholangiocarcinoma (ICC) and cirrhosis, yet the survival …
Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the U Nited S tates
Background Curative surgical treatments afford the best prognosis for patients with
intrahepatic cholangiocarcinoma (iCCA); however, the comparative effectiveness of …
intrahepatic cholangiocarcinoma (iCCA); however, the comparative effectiveness of …
Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics
Purpose Incidence and mortality of intrahepatic cholangiocarcinoma (ICC) have been
increasing over the past few decades, and Ki67 is an adverse prognostic predictor and an …
increasing over the past few decades, and Ki67 is an adverse prognostic predictor and an …
Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
N Thakral, T Gonzalez, O Nano, SH Shin… - BMC …, 2023 - Springer
Context Cholangiocarcinoma (CCA), a malignancy of the biliary tract epithelium is of
increasing importance due to its rising incidence worldwide. There is a lack of data on …
increasing importance due to its rising incidence worldwide. There is a lack of data on …
Incidental diffuse low-grade gliomas: a systematic review and meta-analysis of treatment results with correction of lead-time and length-time biases
S Nakasu, Y Nakasu, A Tsuji, T Fukami… - Neuro-Oncology …, 2023 - academic.oup.com
Background Better overall survival (OS) reported in patients with incidental diffuse low-grade
glioma (iLGG) in comparison to symptomatic LGG (sLGG) may be overestimated by lead …
glioma (iLGG) in comparison to symptomatic LGG (sLGG) may be overestimated by lead …